TL;DR
While over 80% of pregnant women in Canada use folic acid (FA) supplements, only 16.5% of non-pregnant females of childbearing age do so, despite public health recommendations. This study highlights a critical "preconception gap" and identifies significant sociodemographic disparities—particularly linked to awareness of the folic acid-birth defect connection—that put certain populations at higher risk for neural tube defects (NTDs).
What Problem Does This Paper Address?
Neural tube defects (NTDs) occur very early in gestation (weeks 3–4), often before a person even knows they are pregnant. Because roughly 40–50% of pregnancies in North America are unplanned, maintaining adequate folate status is a constant public health priority for anyone of childbearing age.
While Canada implemented mandatory folic acid fortification of white flour and pasta in 1998, fortification alone isn't enough to bring everyone up to the optimal levels required for maximal NTD risk reduction. Consequently, Canadian guidelines recommend a daily multivitamin containing 400 µg of folic acid for anyone who could become pregnant. This paper evaluates how well these guidelines are actually being followed and identifies which groups are falling through the cracks.
Methods
The researchers conducted a cross-sectional analysis using data from the Canadian Community Health Survey (CCHS), specifically combining the 2015/16 and 2017/18 cycles.
- Population: Females aged 15–55.
- Statistical Approach: The team used representative weighted estimates to project findings across the Canadian population (representing over 9 million women).
- Analysis: They employed multivariable logistic regression to examine associations between supplement use and various sociodemographic, geographic, and health factors.
- Novelty: Unlike previous studies that focused solely on pregnancy, this analysis provides a rare look at supplement use among non-pregnant and lactating women, as well as retrospective data on the "peri-conceptional" period (3 months before and 3 months into pregnancy).
Datasets
The study utilized the Maternal Experiences module of the CCHS.
- Sample Size: 59,345 respondents.
- Cycles: 2015/16 (n=29,635) and 2017/18 (n=29,710).
- Comparison: The authors compared their findings against older data from the 2006-7 Maternity Experiences Survey (MES) and the 2015 CCHS-Nutrition survey to track longitudinal trends.
Key Insights and Ideas
- The Awareness Lever: Awareness of the link between folic acid and birth defects was the strongest predictor of supplement use. Those unaware of the link were 80% less likely to supplement prior to pregnancy.
- The "Double Burden": The same sociodemographic factors associated with lower supplement use (younger age, lower income, smoking, lower education) are also known predictors of lower folate status from diet alone. This creates a compounding risk for these specific subgroups.
- The Nunavut Outlier: Respondents in Nunavut reported significantly lower awareness (18.1%) and supplement use (8.1% among non-pregnant) compared to the rest of Canada, highlighting a persistent geographic inequality in public health reach.
- Behavioral Shift: There is a massive "reactive" surge in supplementation once pregnancy is confirmed (jumping from ~64% pre-pregnancy to ~90% in the first trimester), but this often misses the critical window of neural tube closure.
Key Results
- Current Use Rates:
- Non-pregnant/non-lactating: 16.5%
- Lactating: 58.4%
- Currently Pregnant: 80.3%
- Peri-conceptional Use: Among those who gave birth in the last 5 years, 63.7% took supplements in the 3 months before pregnancy, while 89.9% did so during the first trimester.
- The Knowledge Gap: 23.7% of respondents were unaware that folic acid helps prevent birth defects.
- Sociodemographic Odds: Lower odds of supplement use were consistently associated with being younger (OR 0.70), single (OR 0.4–0.6), having lower educational attainment, and having a household income below the median.
Limitations and Future Work
- Recall Bias: For the peri-conceptional data, women were asked to remember behaviors from up to five years prior.
- Data Granularity: The survey used broad "yes/no" questions regarding folic acid use but did not collect data on the specific dosage (e.g., whether it met the 400 µg recommendation).
- Terminology: The survey specifically asked about "folic acid." Respondents using supplements labeled as "folate" or "5-MTHF" might have answered "no," potentially leading to a slight underestimation.
- Future Directions: The authors suggest that public health initiatives need to move beyond general recommendations and focus on targeted education for high-risk subgroups and non-pregnant women to close the preconception gap.
Summary updated